Related Experiment Videos
Prolonged busulfan-induced remissions in chronic myeloid leukemia
Acta Haematologica
|January 1, 1979
Abstract:
Two prolonged remissions were achieved in a patient with chronic myeloid leukemia by two short courses of busulfan treatment. The first remission lasted for 7 years; the second one lasts already 14 years. In the interval periods no treatment was administered.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dose escalation with simultaneous integrated boost for un-methylated multiple glioblastoma.
Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology·2024
High-precision measurement of the W boson mass with the CDF II detector.
Science (New York, N.Y.)·2022
Search for the Exotic Meson X(5568) with the Collider Detector at Fermilab.
Physical review letters·2018
Combined Forward-Backward Asymmetry Measurements in Top-Antitop Quark Production at the Tevatron.
Physical review letters·2018
Eltrombopag-induced serum pigmentation in severe aplastic anemia: a case report.
Acta haematologica·2026
Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States.
Human vaccines & immunotherapeutics·2026
CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively.
Hematology (Amsterdam, Netherlands)·2026
Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in Australia.
Asia-Pacific journal of clinical oncology·2026